ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2016 ACR/ARHP Annual Meeting

November 11-16, 2016. Washington, DC.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f [g] h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 304
    Gait Abnormalities Due to Hip Osteoarthritis Are Different in Men and Women
  • Abstract Number: 2573
    Galectin 1 As Potential Prognostic Biomarker in Rheumatoid Arthritis
  • Abstract Number: 2751
    Gender and Disease Duration Are Associated with Extra-Articular Manifestations in Axial Spondyloarthropathy
  • Abstract Number: 514
    Gender Difference Is Apparent in the Risk of Forefoot Deformity in Patients with Rheumatoid Arthritis
  • Abstract Number: 2756
    Gender Differences in  Body Composition with Dual-Energy X-Ray Absorptiometry in TNF-α Blocker Naive Ankylosing Spondylitis Patients
  • Abstract Number: 1257
    Gender Differences in Ankylosing Spondylitis Patients Treated with Anti-TNF in Daily Practice with Ten Year Follow up
  • Abstract Number: 1198
    Gene Enrichment Analysis Identifies Active CD40-CD40L Signaling in Early and Established Rheumatoid Arthritis
  • Abstract Number: 1565
    Gene Modules Correlated with Disease Activity and Abatacept Treatment Identified with Weighted Gene Co-Expression Network Analysis of CD4+ T Cell Subsets of RA
  • Abstract Number: 759
    Gene Signature for Glucocorticoid, from in Vitro to In Vivo
  • Abstract Number: 284
    Gene-Environmental Interaction of HLA-DRB1*03:01 and Smoking for the Development of Anti-Jo-1 Autoantibodies in Idiopathic Inflammatory Myopathies: A UK Study
  • Abstract Number: 1803
    General Features of SLE Patients Presenting with Autoimmune Hemolytic Anemia
  • Abstract Number: 2111
    Generation and Characterization of Anti-Citrullinated Protein Antibody-Producing B-Cell Clones
  • Abstract Number: 1485
    Generation of New Carotid Plaque Is Determined By the Prexisting Carotid Atherosclerosis and Ongoning Disease Activity of Rheumatoid Arthritis
  • Abstract Number: 75
    Genetic Analysis of Urate Transporters ABCG2, SLC17A3, SLC22A11 and SLC17A1 in Primary Hyperuricemia and Gout
  • Abstract Number: 297
    Genetic and Environmental Correlation of Osteoarthritis at the Hands, Knees, and Spine
  • Abstract Number: 465
    Genetic and Metabolic Signatures of Purified Synovial Macrophage Subsets during an Acute Murine Model of Inflammatory Arthritis
  • Abstract Number: 2410
    Genetic Architecture of Systemic Juvenile Idiopathic Arthritis Distinguishes It from Oligoarticular and Polyarticular Forms of Juvenile Idiopathic Arthritis
  • Abstract Number: 2695
    Genetic Association of Ankylosing Spondylitis with TBX21 Influences T-Bet and Pro-Inflammatory Cytokine Expression in Humans and SKG Mice As a Model of Spondyloarthritis and Alters Host Microbiome and Response to Microbial Stimuli
  • Abstract Number: 65
    Genetic Heterogeneity in the Risk of Lupus Nephritis According to Ancestry
  • Abstract Number: 2409
    Genetic Insights into Juvenile Idiopathic Arthritis Derived from Deep Whole Genome Sequencing
  • Abstract Number: 57
    Genetic Polymorphism of IL-1RN Encoding the IL-1 Receptor Antagonist Predicts Radiographic Severity of Symptomatic Knee OA
  • Abstract Number: 1837
    Genetic Susceptibility Loci for Systemic Lupus Erythematosus in the Dominican Republic Population
  • Abstract Number: 2715
    Genetic Variants in TNF, TNFRSF1A, and IL23R Are Associated with Risk of Ankylosing Spondylitis
  • Abstract Number: 13
    Genetic Variants of the Vasoactive Intestinal Peptide (VIP) Gen in Association with Rheumatoid Arthritis Treatment Requirements
  • Abstract Number: 3241
    Genetic Variation and Tobacco Smoke Exposure in Systemic Lupus Erythematosus: A Case Control Study Among African Americans
  • Abstract Number: 2032
    Genome-Wide Association Analysis Reveals Novel Juvenile Idiopathic Arthritis Susceptibility Loci
  • Abstract Number: 3230
    Genome-Wide Association Study Identifies Novel Sjögren’s Syndrome Risk Loci in the Regions of NAB1, TYK2, and PTTG1-mir146a
  • Abstract Number: 2720
    Genome-Wide Association Study of Clinical Phenotypes in Psoriatic Arthritis
  • Abstract Number: 2275
    Genome-Wide Association Study of Gout in New Zealand Polynesian People
  • Abstract Number: 3122
    Genome-Wide DNA Methylation Association Study of Hand Osteoarthritis
  • Abstract Number: 2879
    Genome-Wide Pathway Analysis Reveals That VEGF Genetic Pathway Is Associated with Oral Ulcers in Systemic Lupus Erythematosus
  • Abstract Number: 647
    Genomic and Epigenetic Bioinformatics Demonstrate Dual TNF-α and IL17A Target Engagement By ABT-122, and Suggest Mainly TNF-α–Mediated Relative Target Contribution to Drug Response in MTX-IR Rheumatoid Arthritis Patients
  • Abstract Number: 885
    Giant Cell Arteritis and Malignancy – More Than Just a Coincidence?
  • Abstract Number: 878
    Giant-Cell Arteritis Related Stroke: A Retrospective Multicentre Case-Control Study
  • Abstract Number: 1103
    Gingival Tissue-Derived MSC Cells (GMSC) Suppress Osteoclastogenesis and Bone Erosion in Collagen-Induced Arthritis Thought CD73 Signal Pathway
  • Abstract Number: 2673
    Glandular Ultrasonography in Primary SjöGren Syndrome: Clinical and Laboratory Correlation
  • Abstract Number: 2078
    Global Ethnic and Geographic Differences in the Clinical Features of ANCA-Associated Vasculitis
  • Abstract Number: 438
    Glucocorticoid Adverse Effects – the Patient Perspective
  • Abstract Number: 1031
    Glucocorticoid Receptor Dimerization in Stromal Cells Modulates Macrophage Polarization during Serum Transfer-Induced Arthritis
  • Abstract Number: 2544
    Glucocorticoid Treatment for 12 Weeks in Early Rheumatoid Arthritis Is Related to an Increase in BMI
  • Abstract Number: 2541
    Glucocorticoid Use and Low Thoracic Bone Mineral Density Are Predictors for Clinical Fractures in Patients with Rheumatoid Arthritis: Five-Year Findings of the Tomorrow Study
  • Abstract Number: 2246
    Glucocorticoids in Early Rheumatoid Arthritis Management, Friend or Foe?
  • Abstract Number: 288
    Glucose Homeostasis Influences the Risk of Incident Knee Osteoarthritis
  • Abstract Number: 1451
    Glutamine Metabolism Plays a Crucial Role in the Pathogenesis of Rheumatoid Arthritis
  • Abstract Number: 584
    Glycoprotein VI: A Potential Target for ACPA-Mediated Platelet Activation?
  • Abstract Number: 629
    Golimumab Improves Patient-Reported Outcomes and Socio- and Health-Economic Parameters in Patients with Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), and Ankylosing Spondylitis (AS): Results from a Non-Interventional Clinical Evaluation in Germany
  • Abstract Number: 413
    Golimumab in Refractory Uveitis Associated to Juvenile Idiopathic Arthritis. Multicenter Study of 7 Cases and Literature Review
  • Abstract Number: 2301
    Gout and Subsequent Risk of Incident Erectile Dysfunction: A Population-Based Cohort Study from the United Kingdom
  • Abstract Number: 519
    Greater Fatigue at Baseline and Female Gender Predict Worse Disability in Early RA Despite Treatment to Target: A Comparison of Two Observational Cohort Studies from the United Kingdom
  • Abstract Number: 2998
    Gut Microbiota Induce IGF-1 and Promote Bone Formation and Growth
Jump to:  View All • a b c d e f [g] h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology